FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Estraderm TTS 100 patches (Novartis Pharmaceuticals UK Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Norgine Pharmaceuticals Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 5mg patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 5mg patches (Pfizer Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 5mg patches (The Boots Company) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 5mg patches (The Boots Company) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 5mg patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 5mg patches (Waymade Healthcare Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 10mg/16hours patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 10mg patches (Pfizer Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 10mg patches (The Boots Company) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 10mg patches (Waymade Healthcare Plc) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 10mg patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette 10mg patches (Pfizer Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist 10mg patches (The Boots Company) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 10mg/16hours patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 10mg/16hours patches (McNeil Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Andropatch 5mg/24hours patches (GlaxoSmithKline) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Andropatch 5mg/24hours patches (GlaxoSmithKline) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 3 patches (Boehringer Ingelheim Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 3 patches (Boehringer Ingelheim Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nitro-Dur 0.4mg/hour transdermal patches (Organon Pharma (UK) Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Forum Health Products Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours patches (PI) (Waymade Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Doncaster Pharmaceuticals Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 10 transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Waymade Healthcare Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours patches 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (PI) (Dowelhurst Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Waymade Healthcare Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours patches (PI) (Waymade Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Sigma Pharmaceuticals Plc) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Sigma Pharmaceuticals Plc) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Sigma Pharmaceuticals Plc) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nitro-Dur 0.4mg/hour transdermal patches (Organon Pharma (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Trintek 10 transdermal patches (Goldshield Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Minitran 10 transdermal patches (Viatris UK Healthcare Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Deponit 10 transdermal patches (Forum Health Products Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Trintek 10 transdermal patches (Goldshield Healthcare Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (PI) (Dowelhurst Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Novartis Pharmaceuticals UK Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Andropatch 2.5mg/24hours patches (GlaxoSmithKline) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Andropatch 2.5mg/24hours patches (GlaxoSmithKline) 60 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours patches 60 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours transdermal patch Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours patches 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 25mg/16hours transdermal patches 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 11 of 21 Next End

This concept is not in any reference sets

Back to Start